These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38164954)

  • 1. Preparation and characterization of inactivated tick-borne encephalitis virus samples for single-particle imaging at the European XFEL.
    Vorovitch MF; Samygina VR; Pichkur E; Konarev PV; Peters G; Khvatov EV; Ivanova AL; Tuchynskaya KK; Konyushko OI; Fedotov AY; Armeev G; Shaytan KV; Kovalchuk MV; Osolodkin DI; Egorov AM; Ishmukhametov AA
    Acta Crystallogr D Struct Biol; 2024 Jan; 80(Pt 1):44-59. PubMed ID: 38164954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure of inactivated mature tick-borne encephalitis virus at 3.0 Å resolution.
    Pichkur EB; Vorovitch MF; Ivanova AL; Protopopova EV; Loktev VB; Osolodkin DI; Ishmukhametov AA; Samygina VR
    Emerg Microbes Infect; 2024 Dec; 13(1):2313849. PubMed ID: 38465849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
    Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
    mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
    Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
    Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure of tick-borne encephalitis virus determined at X-ray free-electron lasers. Simulations.
    Assalauova D; Vartanyants IA
    J Synchrotron Radiat; 2023 Jan; 30(Pt 1):24-34. PubMed ID: 36601923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization and immunogenicity of a novel vaccine candidate against tick-borne encephalitis virus based on Leishmania-derived virus-like particles.
    Zimna M; Brzuska G; Salát J; Svoboda P; Baranska K; Szewczyk B; Růžek D; Krol E
    Antiviral Res; 2023 Jan; 209():105511. PubMed ID: 36581050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Energy Electron Irradiation of Tick-Borne Encephalitis Virus Provides a Protective Inactivated Vaccine.
    Finkensieper J; Issmail L; Fertey J; Rockstroh A; Schopf S; Standfest B; Thoma M; Grunwald T; Ulbert S
    Front Immunol; 2022; 13():825702. PubMed ID: 35340807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel virus-like particle-based vaccine for preventing tick-borne encephalitis virus infection.
    Tang J; Fu M; Xu C; Xue B; Zhou A; Chen S; Zhao H; Zhou Y; Chen J; Yang Q; Chen X
    Virol Sin; 2023 Oct; 38(5):767-777. PubMed ID: 37328107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant chimeric Japanese encephalitis virus/tick-borne encephalitis virus is attenuated and protective in mice.
    Wang HJ; Li XF; Ye Q; Li SH; Deng YQ; Zhao H; Xu YP; Ma J; Qin ED; Qin CF
    Vaccine; 2014 Feb; 32(8):949-56. PubMed ID: 24394443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine.
    Klockmann U; Krivanec K; Stephenson JR; Hilfenhaus J
    Vaccine; 1991 Mar; 9(3):210-2. PubMed ID: 2042394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of immune response and protective effect of four vaccines against the tick-borne encephalitis virus.
    Morozova OV; Bakhvalova VN; Potapova OF; Grishechkin AE; Isaeva EI; Aldarov KV; Klinov DV; Vorovich MF
    Vaccine; 2014 May; 32(25):3101-6. PubMed ID: 24631082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and immunogenicity of a veterinary vaccine candidate against tick-borne encephalitis in dogs.
    Salat J; Hunady M; Svoboda P; Strelcova L; Strakova P; Fortova A; Palus M; Ruzek D
    Vaccine; 2023 Oct; 41(42):6150-6155. PubMed ID: 37716828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and Characterization of a Chimeric Tick-Borne Encephalitis Virus Attenuated Strain ChinTBEV.
    Wang HJ; Li XF; Qin CF
    Methods Mol Biol; 2016; 1403():285-93. PubMed ID: 27076137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinction between serological responses following tick-borne encephalitis virus (TBEV) infection vs vaccination, Sweden 2017.
    Albinsson B; Vene S; Rombo L; Blomberg J; Lundkvist Å; Rönnberg B
    Euro Surveill; 2018 Jan; 23(3):. PubMed ID: 29386094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial.
    Sandberg JT; Löfling M; Varnaitė R; Emgård J; Al-Tawil N; Lindquist L; Gredmark-Russ S; Klingström J; Loré K; Blom K; Ljunggren HG
    PLoS Negl Trop Dis; 2023 Feb; 17(2):e0010616. PubMed ID: 36758067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice.
    Ershova AS; Gra OA; Lyaschuk AM; Grunina TM; Tkachuk AP; Bartov MS; Savina DM; Sergienko OV; Galushkina ZM; Gudov VP; Kozlovskaya LI; Kholodilov IS; Gmyl LV; Karganova GG; Lunin VG; Karyagina AS; Gintsburg AL
    BMC Infect Dis; 2016 Oct; 16(1):544. PubMed ID: 27717318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
    Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines.
    Ruzek D; Avšič Županc T; Borde J; Chrdle A; Eyer L; Karganova G; Kholodilov I; Knap N; Kozlovskaya L; Matveev A; Miller AD; Osolodkin DI; Överby AK; Tikunova N; Tkachev S; Zajkowska J
    Antiviral Res; 2019 Apr; 164():23-51. PubMed ID: 30710567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The envelope protein of tick-borne encephalitis virus influences neuron entry, pathogenicity, and vaccine protection.
    Lindqvist R; Rosendal E; Weber E; Asghar N; Schreier S; Lenman A; Johansson M; Dobler G; Bestehorn M; Kröger A; Överby AK
    J Neuroinflammation; 2020 Sep; 17(1):284. PubMed ID: 32988388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Basis of a Protective/Neutralizing Monoclonal Antibody Targeting Envelope Proteins of both Tick-Borne Encephalitis Virus and Louping Ill Virus.
    Yang X; Qi J; Peng R; Dai L; Gould EA; Gao GF; Tien P
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30760569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.